PROKIDNEY CORP
CLASS A ORD SHS · CUSIP G7S53R104
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $2.04.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 19 |
| Q4 2022 | 28 |
| Q1 2023 | 36 |
| Q2 2023 | 57 |
| Q3 2023 | 67 |
| Q4 2023 | 62 |
| Q1 2024 | 56 |
| Q2 2024 | 67 |
| Q3 2024 | 72 |
| Q4 2024 | 76 |
| Q1 2025 | 70 |
| Q2 2025 | 51 |
| Q3 2025 | 4 |
| Q4 2025 | 1 |
| Q1 2026 | 1 |
| Q2 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 50 | 18 |
| Q4 2024 | 42 | 30 |
| Q1 2025 | 35 | 28 |
| Q2 2025 | 29 | 51 |
| Q3 2025 | 1 | 49 |
| Q4 2025 | 0 | 3 |
| Q1 2026 | 0 | 0 |
| Q2 2026 | 0 | 0 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Tolerantia, LLC 13D · may seek influence -1.5 pts · filed 2025-06-05 | 36.5% |
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Brown University 2.14% of their portfolio | 1.0m $2.0m | Unchanged |